VAXCYTE, INC. Public Float
VAXCYTE, INC. (PCVX) had Public Float of $3.70 billion as of 2025-06-30, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-24
- 2025-06-30: Entity Public Float $3.70B.
- 2024-06-30: Entity Public Float $7.20B.
- 2023-06-30: Entity Public Float $4.10B.
- 2022-06-30: Entity Public Float $1.10B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $3.70B 10-K · filed 2026-02-24 |
| 2024-06-30 | $7.20B 10-K · filed 2025-02-25 |
| 2023-06-30 | $4.10B 10-K · filed 2024-02-27 |
| 2022-06-30 | $1.10B 10-K · filed 2023-02-27 |
| 2021-06-30 | $788.60M 10-K · filed 2022-02-28 |
| 2020-06-30 | $949.50M 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |